Position in CDXS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$78,704
+$19,606 QoQ
Shares Held
34,825
-3.9% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 31 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krilogy Financial LLC holds $9,897,448 across 23 Biotechnology names. CDXS ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
24,744 | $2,804,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,878 | $1,171,008 | |
| 3 | EXEL |
Exelixis, Inc.
|
21,072 | $1,146,527 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
14,648 | $838,158 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,221 | $606,507 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
6,111 | $531,351 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,064 | $497,362 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
11,941 | $398,709 |
All Filings in CDXS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,704 | 34,825 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $59,098 | 36,257 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $49,064 | 30,101 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $73,270 | 30,029 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||